286 related articles for article (PubMed ID: 26226572)
1. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC
Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
[TBL] [Abstract][Full Text] [Related]
2. Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism.
Kabir I; Li Z; Bui HH; Kuo MS; Gao G; Jiang XC
J Biol Chem; 2016 Apr; 291(14):7651-60. PubMed ID: 26828064
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet.
Wang B; Rong X; Duerr MA; Hermanson DJ; Hedde PN; Wong JS; Vallim TQ; Cravatt BF; Gratton E; Ford DA; Tontonoz P
Cell Metab; 2016 Mar; 23(3):492-504. PubMed ID: 26833026
[TBL] [Abstract][Full Text] [Related]
4. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine.
Nassir F; Wilson B; Han X; Gross RW; Abumrad NA
J Biol Chem; 2007 Jul; 282(27):19493-501. PubMed ID: 17507371
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport.
Hashidate-Yoshida T; Harayama T; Hishikawa D; Morimoto R; Hamano F; Tokuoka SM; Eto M; Tamura-Nakano M; Yanobu-Takanashi R; Mukumoto Y; Kiyonari H; Okamura T; Kita Y; Shindou H; Shimizu T
Elife; 2015 Apr; 4():. PubMed ID: 25898003
[TBL] [Abstract][Full Text] [Related]
6. Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol.
Li Z; Park TS; Li Y; Pan X; Iqbal J; Lu D; Tang W; Yu L; Goldberg IJ; Hussain MM; Jiang XC
Biochim Biophys Acta; 2009 Apr; 1791(4):297-306. PubMed ID: 19416652
[TBL] [Abstract][Full Text] [Related]
7. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.
Rong X; Wang B; Dunham MM; Hedde PN; Wong JS; Gratton E; Young SG; Ford DA; Tontonoz P
Elife; 2015 Mar; 4():. PubMed ID: 25806685
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity.
He M; Li Z; Tung VSK; Pan M; Han X; Evgrafov O; Jiang XC
Diabetes; 2023 Nov; 72(11):1547-1559. PubMed ID: 37625119
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.
Li Z; Ding T; Pan X; Li Y; Li R; Sanders PE; Kuo MS; Hussain MM; Cao G; Jiang XC
J Biol Chem; 2012 Jun; 287(24):20122-31. PubMed ID: 22511767
[TBL] [Abstract][Full Text] [Related]
10. Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling.
Kazachkov M; Chen Q; Wang L; Zou J
Lipids; 2008 Oct; 43(10):895-902. PubMed ID: 18781350
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway.
Feng C; Lou B; Dong J; Li Z; Chen Y; Li Y; Zhang X; Jiang XC; Ding T
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):834-843. PubMed ID: 29673706
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.
Cash JG; Hui DY
Nutr Diabetes; 2016 Apr; 6(4):e206. PubMed ID: 27110687
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Cgi-58 deficiency reduces postprandial lipid absorption.
Xie P; Guo F; Ma Y; Zhu H; Wang F; Xue B; Shi H; Yang J; Yu L
PLoS One; 2014; 9(3):e91652. PubMed ID: 24618586
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid transfer protein-deficient mice absorb less cholesterol.
Liu R; Iqbal J; Yeang C; Wang DQ; Hussain MM; Jiang XC
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):2014-21. PubMed ID: 17641249
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
Zhao Y; Chen YQ; Bonacci TM; Bredt DS; Li S; Bensch WR; Moller DE; Kowala M; Konrad RJ; Cao G
J Biol Chem; 2008 Mar; 283(13):8258-65. PubMed ID: 18195019
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice.
Shim J; Moulson CL; Newberry EP; Lin MH; Xie Y; Kennedy SM; Miner JH; Davidson NO
J Lipid Res; 2009 Mar; 50(3):491-500. PubMed ID: 18843142
[TBL] [Abstract][Full Text] [Related]
18. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis.
Davis HR; Zhu LJ; Hoos LM; Tetzloff G; Maguire M; Liu J; Yao X; Iyer SP; Lam MH; Lund EG; Detmers PA; Graziano MP; Altmann SW
J Biol Chem; 2004 Aug; 279(32):33586-92. PubMed ID: 15173162
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse Model.
Jiang H; Li Z; Huan C; Jiang XC
Front Cardiovasc Med; 2018; 5():192. PubMed ID: 30705887
[TBL] [Abstract][Full Text] [Related]
20. Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.
Zhong CY; Sun WW; Ma Y; Zhu H; Yang P; Wei H; Zeng BH; Zhang Q; Liu Y; Li WX; Chen Y; Yu L; Song ZY
Sci Rep; 2015 May; 5():10512. PubMed ID: 26015368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
